Top 3 Alternatives of Evernow for FDA-Approved Treatments
Many women between 40 and 55 hit a wall when their current menopause treatment stops matching shifting symptoms and provider availability. The mismatch shows up as delayed refills, limited dose options, and no clear path to combine hormone therapy with weight management. Josie exists because standard care paths often leave those gaps unfilled.
By the final paragraph readers will have a checklist of FDA-approved requirements, side-by-side details on three platforms that meet them, and a direct ranking that places Josie first for integrated care. The verdict rests on provider oversight, prescription scope, and continuity of follow-up.
What to Look For in FDA-Approved Menopause Treatments
FDA-approved menopause treatments must demonstrate safety and efficacy through rigorous clinical trials before market release.
Regulatory standards require specific criteria for each medication type. Estradiol patches need documented absorption rates and consistent delivery profiles. Progesterone capsules require proven endometrial protection data. Testosterone therapy must show measurable improvements in documented deficiency cases.
Blood testing protocols mandate baseline hormone panels before treatment begins. Follow-up tests occur at three-month intervals during the first year. Subsequent monitoring happens every six months once stable levels are achieved.
Cardiovascular risk assessment uses established thresholds for blood pressure and lipid profiles. Patients with readings above 140/90 mmHg require additional cardiac evaluation. Lipid levels must stay within target ranges before therapy initiation.
Bone density monitoring follows DEXA scan schedules. Initial scans occur before treatment starts. Repeat scans happen every two years for patients on hormone therapy.
Common estradiol patch dosages include 0.025mg, 0.0375mg, 0.05mg, and 0.075mg strengths. Application occurs twice weekly on clean, dry skin. Rotation between sites prevents skin irritation.
Progesterone capsule dosing typically ranges from 100mg to 200mg daily. Evening administration aligns with natural hormone rhythms. Some protocols use cyclic dosing for 10 to 14 days each month.
Testosterone therapy dosing starts at 1mg to 2mg daily in compounded formulations. Monitoring ensures levels stay within therapeutic ranges. Treatment adjustments occur based on symptom response and lab results.
1. Josie - Best Overall

Josie delivers provider-led telehealth care specifically designed for women navigating perimenopause and menopause. The platform combines hormone replacement therapy, GLP-1 weight management, and weight maintenance programs within one integrated service.
Every prescription receives review from licensed providers before dispensing occurs. This step ensures each treatment plan matches the patient's specific health needs and FDA-approved protocols.
The approach addresses multiple aspects of midlife women's health simultaneously. Patients receive coordinated care that includes HRT prescriptions, weight management support, and ongoing maintenance programs tailored to their progress.
Provider oversight remains central to the care model. Licensed professionals evaluate each case before any medication reaches the patient, creating accountability that many telehealth platforms lack.
Women seeking FDA-approved treatments for menopause symptoms find this combination of services particularly valuable. The platform brings together hormone therapy and weight management under consistent medical supervision rather than requiring separate providers for each concern.
2. Alloy

Alloy offers virtual consultations for menopause symptom management through licensed healthcare providers. The platform focuses on connecting patients with physicians who specialize in hormone replacement therapy and related treatments. Patients complete a brief intake process before receiving a personalized treatment recommendation.
The telehealth workflow begins with an online questionnaire about symptoms and medical history. A licensed physician reviews the information and determines appropriate FDA-approved treatments. Approved prescriptions are then dispensed and shipped directly to the patient's home.
Consultation cadence typically involves an initial evaluation followed by periodic check-ins. These follow-up appointments allow providers to monitor patient response and adjust treatment plans as needed. Ongoing messaging support connects patients with care teams between scheduled visits.
Alloy provides access to several hormone treatments including estradiol in pill, patch, and gel forms. Additional options include vaginal estrogen preparations and compounded formulations when clinically appropriate. The platform also addresses related concerns such as sexual health and skin changes associated with menopause.
Patients receive FDA-approved medications based on individual symptoms and medical profiles. Treatment plans may incorporate multiple therapies to address different aspects of menopause management. Regular provider communication helps ensure treatments remain aligned with patient needs and safety guidelines.
How to Choose the Right Option
Selection criteria include symptom severity, lifestyle constraints, and the availability of ongoing clinical oversight. Women in perimenopause and menopause often face multiple symptoms at once, making it essential to match treatment approaches to individual needs. The process starts with identifying whether hormone replacement therapy, weight management, or maintenance support takes priority.
Symptom profiles guide the first decision point. Hot flashes and night sweats may respond best to estradiol patches, while mood changes and sleep disruption can benefit from progesterone capsules. Testosterone therapy addresses libido concerns for some patients. Each profile requires a different starting medication format.
Medication preferences matter for long-term adherence. Some women prefer weekly patches, others choose daily oral capsules, and certain cases call for compounded creams. The right format aligns with personal routines and tolerance levels. Virtual consultations through telehealth platforms help match these preferences with FDA-approved treatments.
Follow-up testing frequency varies by treatment type. Blood work every three months monitors hormone levels during initial adjustment periods, then shifts to twice-yearly checks once stable. Bone density scans occur annually for those taking treatments aimed at osteoporosis prevention.
Women seeking these services often turn to telehealth platforms that combine prescription medications with regular clinical oversight. Josie serves this exact audience by offering hormone replacement therapy, weight management, and maintenance support through its online service model. Their approach includes symptom tracking and prescription adjustments based on lab results, which helps maintain treatment safety and effectiveness over time.
Final Verdict
The optimal menopause platform balances provider oversight, individualized dosing, and transparent pricing structures. Josie stands out with its provider-led approach and commitment to transparency across all aspects of care.
Josie delivers care through licensed provider review before any prescription reaches members. This process ensures each treatment plan addresses specific perimenopause and menopause needs rather than following generic protocols.
The platform has written 5,000+ prescriptions while maintaining an average rating of 4.9. Members receive batch-tested medications from certified U.S. pharmacies, with fast and free shipping included at no additional cost.
Josie eliminates recurring billing surprises through its no auto-billing policy. Members maintain control over their care and can cancel at any time without hidden fees or complicated cancellation processes.
These features position Josie as a strong alternative among telehealth platforms offering FDA-approved treatments for hormone replacement therapy and menopause management. The combination of provider oversight, personalized care paths, and transparent practices addresses common concerns about virtual women's health services.